Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
letter
. 2014 Dec 19;58(1):111–113. doi: 10.1007/s11427-014-4790-3

Do corticosteroids have a role in treating Ebola virus disease?

Jun Xu 1, DingYu Tan 1, YangYang Fu 1, Joseph Walline 2, XueZhong Yu 1,
PMCID: PMC7088570  PMID: 25558864

The content is available as a PDF (398.4 KB).

Footnotes

Contributed equally to this work

This article is published with open access at link.springer.com

References

  • 1.WHO Ebola Response Team. N Engl J Med. 2014. Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Wong G, Kobinger GP, Qiu X. Characterization of host immune responses in Ebola virus infections. Expert Rev Clin Immunol. 2014;10:781–790. doi: 10.1586/1744666X.2014.908705. [DOI] [PubMed] [Google Scholar]
  • 3.Sanchez A, Lukwiya M, Bausch D, Mahanty S, Sanchez AJ, Wagoner KD, Rollin PE. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitricoxide levels. J Virol. 2004;78:10370–10377. doi: 10.1128/JVI.78.19.10370-10377.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wauquier N, Becquart P, Padilla C, et al. Human fatal Zaire Ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis. 2010;4:10. doi: 10.1371/journal.pntd.0000837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Leroy EM, Baize S, Debre P, Lansoud-Soukate J, Mavoungou E. Early immune responses accompanying human asymptomatic Ebola infections. Clin Exp Immunol. 2001;124:453–460. doi: 10.1046/j.1365-2249.2001.01517.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Geisbert TW, Hensley LE, Larsen T, Young HA, Reed DS, Geisbert JB, Scott DP, Kagan E, Jahrling PB, Davis KJ. Pathogenesis of Ebola haemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol. 2003;163:2347–2370. doi: 10.1016/S0002-9440(10)63591-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Sharifi-Mood B, Alavi-Naini R, Metanat M, Mohammadi M, Shakeri A, Amjadi A. Efficacy of high-dose methylprednisolone in patients with Crimean-Congo haemorrhagic fever and severe thrombocytopenia. Trop Doct. 2013;43:49–53. doi: 10.1177/0049475513486642. [DOI] [PubMed] [Google Scholar]
  • 8.Rajapakse S. Corticosteroids in the treatment of dengue illness. Trans R Soc Trop Med Hyg. 2009;103:122–126. doi: 10.1016/j.trstmh.2008.07.022. [DOI] [PubMed] [Google Scholar]
  • 9.Erduran E, Bahadir A, Palanci N, Gedik Y. The treatment of Crimean-Congo hemorrhagic fever with high-dose methylprednisolone, intravenous immunoglobulin, and fresh frozen plasma. J Pediatr Hematol Oncol. 2013;35:e19–24. doi: 10.1097/MPH.0b013e3182706444. [DOI] [PubMed] [Google Scholar]
  • 10.Shashidhara KC, Murthy KAS, Gowdappa HB, Bhograj A. Effect of high dose of steroid on platelet count in acute stage of dengue fever with thrombocytopenia. J Clin Diagn Res. 2013;7:1397–1400. doi: 10.7860/JCDR/2013/6135.3143. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Science China. Life Sciences are provided here courtesy of Nature Publishing Group

RESOURCES